Stock Market News4 weeks AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study Zacks
Akero stock soars 106% in a week following initial positive top line 96-week data from a mid-stage MASH study of its lead product candidate, EFX.
XAkero stock soars 106% in a week following initial positive top line 96-week data from a mid-stage MASH study of its lead product candidate, EFX.
X